A major study lifts a cloud around Zetia and Vytorin, blockbuster drugs for lowering cholesterol. The study found that these pills modestly lower the risk of heart attacks and other problems in people at high risk for them—evidence ...
Nov 17, 2014
0
0
Scientists have discovered gene mutations that give people naturally lower cholesterol levels and cut their risk of heart disease in half.
Nov 12, 2014
0
1
Evolocumab, an injected form of a new class of drugs called PCSK9 inhibitors[1], is highly effective at reducing low-density lipoprotein (LDL) or "bad cholesterol" levels with few side effects in people with familial hypercholesterolaemia ...
Oct 2, 2014
0
0
(Medical Xpress)—New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.
Aug 26, 2014
0
0
(Medical Xpress)—Researchers have found a new class of drugs can improve the ability of particles in the blood which can increase so-called 'good' cholesterol's ability to clear away fat from blood vessel walls.
Mar 19, 2014
0
0
(HealthDay)—A new analysis suggests that people at high risk for heart disease who can't take high-dose statin drugs to lower their cholesterol might benefit from a treatment combination that includes taking a low-dose ...
Feb 10, 2014
0
0
(Medical Xpress)—A leading cardiology expert at the University of Adelaide predicts that a new class of advanced cholesterol-reducing drugs could be ready for patient use within the next five years, helping to prevent heart ...
Feb 3, 2014
0
0
(HealthDay)—Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock.
Jan 14, 2014
0
0
New research that looked at whether two commonly prescribed statin medicines, used to lower low-density lipoprotein (LDL) or 'bad cholesterol' levels in the blood, can adversely affect cognitive function has found that one ...
Sep 25, 2013
1
0
A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol – drugs that offer them no benefit and may increase other ...
Sep 10, 2013
0
0
